| Structure | Chemical Name | CAS | MF |
|
5α-Cholesta-9(11),17(20),24-triene-3β,6α-diol diacetate
|
37926-47-9
|
C31H46O4
|
|
(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylic acid
|
37926-75-3
|
C21H27FO5
|
|
(-)-Dexamethasone Acid
|
37927-01-8
|
C21H27FO5
|
|
(11beta,17alpha)-11,17-dihydroxy-3-oxoandrosta-1,4-diene-17-carboxylic acid
|
37927-29-0
|
C20H26O5
|
|
5-Methyl-3,4-diphenylisoxazole
|
37928-17-9
|
C16H13NO
|
|
1,4,4,6-Tetramethyl-3,4-dihydropyrimidine-2(1H)-thione
|
37929-27-4
|
C8H14N2S
|
|
1-Butyl-3,4-dihydro-4,4,6-trimethyl-2(1H)-pyrimidinethione
|
37929-28-5
|
C11H20N2S
|
|
BENZENECARBOHYDRAZONOYL CHLORIDE
|
37932-51-7
|
C14H8Cl4N2
|
|
4-[(4-chlorophenyl)methyl]-2-(hexahydro-1-methyl-1H-azepin-4-yl)phthalazin-1(2H)-one hydrochloride
|
37932-96-0
|
C22H25Cl2N3O
|
|
4-[(3-Chlorophenyl)Methyl]-2-(hexahydro-1-Methyl-1H-azepin-4-yl)-1(2H)-phthalazinone
|
37933-01-0
|
C22H24ClN3O
|
|
1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-isoquinoline, 1-sulfooxy dodecane
|
37933-68-9
|
C32H47NO8S
|
|
L-lysine o-acetoxybenzoate
|
37933-78-1
|
C15H22N2O6
|
|
AC-VAL-NH2
|
37933-88-3
|
C7H14N2O2
|
|
red pigment-concentrating hormone
|
37933-92-9
|
C45H59N11O11
|
|
xanthonolol
|
37933-99-6
|
C19H21NO4
|
|
2-(diethoxyphosphorylsulfanylmethyl)-5-methyl-1,3,4-oxadiazole
|
37934-12-6
|
C8H15N2O4PS
|
|
(5-ethyl-1,3,4-oxadiazol-2-yl)methylsulfanyl-dimethoxy-sulfanylidene-p hosphorane
|
37934-13-7
|
C7H13N2O3PS2
|
|
2-(diethoxyphosphorylsulfanylmethyl)-5-ethyl-1,3,4-oxadiazole
|
37934-14-8
|
C9H17N2O4PS
|
|
2-(diethoxyphosphorylsulfanylmethyl)-5-propyl-1,3,4-oxadiazole
|
37934-17-1
|
C10H19N2O4PS
|
|
Pentanoic acid, 5-((3-amino-2,4,6-triiodophenyl)ethylamino)-5-oxo- (9C I)
|
37934-61-5
|
C13H15I3N2O3
|
|
3-[[N-(3-Amino-2,4,6-triiodophenyl)-N-propylamino]carbonyl]propionic acid
|
37934-63-7
|
C13H15I3N2O3
|
|
5-[N-Ethyl-N-(5-amino-2,4-diiodophenyl)amino]-5-oxopentanoic acid
|
37934-66-0
|
C13H16I2N2O3
|
|
3-[(5-amino-2,4-diiodo-phenyl)-ethyl-carbamoyl]propanoic acid
|
37934-68-2
|
C12H14I2N2O3
|
|
Methyl 4-methoxy-2,6-dimethylbenzoate
|
37934-88-6
|
C11H14O3
|
|
2,6-DIMETHYL-4-METHOXYBENZOIC ACID
|
37934-89-7
|
C10H12O3
|
|
Benzoic acid 2,2,2-trichloroethyl ester
|
37934-99-9
|
C9H7Cl3O2
|
|
2-[[(8E,10E)-8,10-Dodecadienyl]oxy]tetrahydro-2H-pyran
|
37935-49-2
|
C17H30O2
|
|
2-[4-[(hexahydro-2,4,6-trioxopyrimidin-5-yl)azo]phenyl]-6-methylbenzothiazole-7-sulphonic acid
|
37936-41-7
|
C18H13N5O6S2
|
|
eremanthin
|
37936-58-6
|
C15H18O2
|
|
JP 92, NSC 43036, S-(+)-α-Methyl-3-(trifluoromethyl)benzeneethanamine hydrochloride
|
37936-89-3
|
C10H12F3N.ClH
|
|
5-Phenyl-1,2,4-oxadiazole-3-carboxylic acid
|
37937-62-5
|
C9H6N2O3
|
|
3-[(5-Amino-2,4-diiodophenyl)carbamoyl]propionic acid
|
37938-58-2
|
C10H10I2N2O3
|
|
Butanoic acid, 4-(methyl(2,4,6-triiodo-3-propoxyphenyl)amino)-4-oxo-
|
37938-64-0
|
C14H16I3NO4
|
|
3-[[N-(3-Ethoxy-2,4,6-triiodophenyl)-N-methylamino]carbonyl]propionic acid
|
37938-65-1
|
C13H14I3NO4
|
|
3-[[N-(3-Propoxy-2,4,6-triiodophenyl)-N-propylamino]carbonyl]propionic acid
|
37938-70-8
|
C16H20I3NO4
|
|
3-[[N-(3-Ethoxy-2,4,6-triiodophenyl)-N-ethylamino]carbonyl]propionic acid
|
37938-74-2
|
C14H16I3NO4
|
|
Butanoic acid, 4-oxo-4-(propyl(2,4,6-triiodo-3-methoxyphenyl)amino)- ( 9CI)
|
37938-78-6
|
C14H16I3NO4
|
|
Benzenemethanol, 2-(2-bromoethyl)--alpha--methyl- (9CI)
|
37939-38-1
|
C10H13BrO
|
|
1,2,7-HEPTANETRIOL
|
37939-50-7
|
C7H16O3
|
|
(E)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one oxime
|
37939-80-3
|
C10H17NO
|
|
4-PROPIONYLBIPHENYL
|
37940-57-1
|
C15H14O
|
|
4-[(4-Chlorophenyl)sulfonyl]benzoic acid
|
37940-65-1
|
C13H9ClO4S
|
|
4-Pyridinamine, N,N,2-trimethyl-
|
37941-24-5
|
C8H12N2
|
|
Z-LYS(Z)-GLY-OH
|
37941-54-1
|
C24H29N3O7
|
|
4-hydroxy-N-methylbutyramide
|
37941-69-8
|
C5H11NO2
|
|
5-Bromo-2-methoxyphenol
|
37942-01-1
|
C7H7BrO2
|
|
3,5-Di-tert-butylsalicylaldehyde
|
37942-07-7
|
C15H22O2
|
|
4-n-Butylcyclohexylamine
|
37942-69-1
|
C10H21N
|
|
N-(4-BUTYLCYCLOHEXYL)ACETAMIDE
|
37942-70-4
|
C12H23NO
|
|
N-(4-BUTYLCYCLOHEXYL)ACETAMIDE
|
37942-71-5
|
C12H23NO
|
|
4-FORMYL-CYCLOHEXANECARBOXYLIC ACID METHYL ESTER
|
37942-76-0
|
C9H14O3
|
|
2-Cyclohexen-1-one,2-amino-(9CI)
|
37942-94-2
|
C6H9NO
|
|
N-methyl pyridinium methyl sulfate
|
37943-43-4
|
|
|
8-benzyl-1,4-dioxa-8-azaspiro[4.5]decane
|
37943-54-7
|
C14H19NO2
|
|
ethyl 3-benzoyl-9-oxo-3-azabicyclo[3.3.1]nonane-7-carboxylate
|
37943-62-7
|
C18H21NO4
|
|
Diphenyl-2-pyridylphosphine
|
37943-90-1
|
C17H14NP
|
|
[5-chloro-2-[3-(chloromethyl)-4H-1,2,4-triazol-4-yl]phenyl] phenyl ketone
|
37945-06-5
|
C16H11Cl2N3O
|
|
Alprazolam EP Impurity F
|
37945-07-6
|
C17H13Cl2N3O
|
|
ETHYL 3-METHYL-4,5,6,7-TETRAHYDRO-1H-INDOLE-2-CARBOXYLATE
|
37945-37-2
|
C12H17NO2
|
|
8,9-Dihydro-5H-benzo[7]annulen-7(6H)-one
|
37949-03-4
|
C11H12O
|
|
4-Fluoro-N-Methyl-N-phenylbenzaMide, 97%
|
37950-87-1
|
C14H12FNO
|
|
(1E,4E)-1,5-Bis(4-methoxyphenyl)penta-1,4-dien-3-one
|
37951-12-5
|
C19H18O3
|
|
FLAVOKAVAIN A(P)
|
37951-13-6
|
C18H18O5
|
|
4-phenoxy-1,2-benzenedicarboxylic acid
|
37951-15-8
|
C14H10O5
|
|
3'-Benzyloxy propiophenone
|
37951-47-6
|
C16H16O2
|
|
3'-methoxypropiophenone
|
37951-49-8
|
C10H12O2
|
|
3-(Dimethylamino)-1-(3-methoxyphenyl)-2-methyl-1-propanone hydrochloride
|
37951-53-4
|
C13H20ClNO2
|
|
3,4-Dihydro-4,4,6-trimethyl-1-(4-methyl-2-nitrophenyl)-2(1H)-pyrimidinethione
|
37951-55-6
|
C14H17N3O2S
|
|
3-ETHOXYPROPANOHYDRAZIDE
|
37952-36-6
|
C5H12N2O2
|
|
4N-Pentylacetophenone
|
37953-02-5
|
C13H18O
|
|
cumenesulphonic acid
|
37953-05-2
|
C9H12O3S
|
|
2-Propenoic acid, 2-methyl-, methyl ester, polymer with butyl 2-propenoate, ethenylbenzene and oxiranylmethyl 2-methyl-2-propenoate
|
37953-21-2
|
C27H38O7
|
|
Methylene, (3,5-dimethyl-4-nitrophenyl)- (9CI)
|
37954-59-9
|
C9H9NO2
|
|
polyurea
|
37955-36-5
|
CH4N2O
|
|
2-Propenoic acid, 2-hydroxy-, homopolymer, sodium salt
|
37956-57-3
|
C3H4O3
|
|
(1)Benzoselenopheno(3,2-b)thiophene
|
37958-13-7
|
C10H6SSe
|
|
benzyl-butoxy-methylsulfanyl-sulfanylidene-phosphorane
|
37958-53-5
|
C12H19OPS2
|
|
(5-OXO-1-PHENYL-2,5-DIHYDRO-1H-PYRAZOL-3-YL)ACETIC ACID
|
37959-11-8
|
C11H10N2O3
|
|
(5-OXO-1-PYRIDIN-2-YL-2,5-DIHYDRO-1H-PYRAZOL-3-YL)ACETIC ACID
|
37959-19-6
|
C10H9N3O3
|
|
1-Ethyl-6-(p-tolyl)-1H-pyrrolo(1,2-a)imidazole
|
37959-37-8
|
C15H16N2
|
|
1,6-Diphenyl-1H-pyrrolo(1,2-a)imidazole
|
37959-38-9
|
C18H14N2
|
|
1-Phenyl-6-(p-tolyl)-1H-pyrrolo(1,2-a)imidazole
|
37959-39-0
|
C19H16N2
|
|
1-Benzyl-6-phenyl-1H-pyrrolo(1,2-a)imidazole
|
37959-40-3
|
C19H16N2
|
|
1H-Pyrrolo(1,2-a)imidazole, 1-benzyl-6-(p-methoxyphenyl)-
|
37959-42-5
|
C20H18N2O
|
|
SEROTONIN BINOXALATE, 5-[2-14C]
|
37960-18-2
|
C14H16N2O9
|
|
BENZOIC-3,5-D2 ACID
|
37960-84-2
|
C7H4D2O2
|
|
5-NITRO-2-FURANACRYLICN-(5-NITRO-2-FURFURYLIDENE)HYDRAZIDE
|
37962-27-9
|
C12H8N4O7
|
|
1,3-bis(2-phenyl-4-chromenon-5-yl)propan-2-ol
|
37962-64-4
|
C33H24O7
|
|
9-ethyl-3H-purine-2,6-dione
|
37962-92-8
|
C7H8N4O2
|
|
1h-carbazole-2-carboxylic acid, 2,3,4,9-tetrahydro-
|
37964-14-0
|
C13H13NO2
|
|
1H-PYRROLE-3-CARBOXYLIC ACID ETHYL ESTER
|
37964-17-3
|
C7H9NO2
|
|
4-amino-3-methoxyphenol hydrochloride
|
37966-57-7
|
C7H10ClNO2
|
|
Tienopramine
|
37967-98-9
|
C17H20N2S
|
|
4H-Thieno(3,2-b)(1)benzazepine-4-propanamine, 9,10-dihydro-N,N-dimethy l-
|
37968-12-0
|
C17H22N2S
|
|
Acetamide, N-2-benzothiazolyl-2-fluoro- (9CI)
|
37968-14-2
|
C9H7FN2OS
|
|
Acetamide, 2-fluoro-N-(4-methyl-2-benzothiazolyl)- (9CI)
|
37968-16-4
|
C10H9FN2OS
|
|
Acetamide, N-2-benzothiazolyl-2-fluoro-N-methyl- (9CI)
|
37968-20-0
|
C10H9FN2OS
|
|
Acetamide, 2-fluoro-N-(6-methyl-2-benzothiazolyl)- (9CI)
|
37968-25-5
|
C10H9FN2OS
|
|
Pyridine, 5-ethyl-2-ethynyl- (9CI)
|
37968-65-3
|
C9H9N
|
|
Pyridine, 2-ethynyl-4,6-dimethyl- (9CI)
|
37968-67-5
|
C9H9N
|